Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Optical Molecular Imaging for Tumor Detection and Image-Guided Surgery.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Optical molecular imaging guided surgical navigation for cancers

New optical molecular imaging systems.

Fluorescent imaging for cancer therapy and cancer gene therapy

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

Optical image-guided cancer therapy.

Optical Molecular Imaging for Early Tumor Diagnosis and Drug Development

Activatable Molecular Probes for Fluorescence-Guided Surgery, Endoscopy and Tissue Biopsy

Activatable fluorescent probes for real-time imaging-guided tumor therapy

Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy

Fluorescence Nanoprobe Imaging Tumor By Sensing The Acidic Microenvironment

Optical Imaging of Tumor Microenvironment

Advances in fluorescence imaging of malignant tumors

Fluorescence Image-Guided Tumour Surgery

Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology

Recent Advances in Optical Imaging of Biomarkers in Vivo

Quicker, Deeper and Stronger Imaging: A Review of Tumor-Targeted, Near-Infrared Fluorescent Dyes for Fluorescence Guided Surgery in the Preclinical and Clinical Stages.

Ph Responsive Fluorescence Nanoprobe Imaging of Tumors by Sensing the Acidic Microenvironment

Advances and Perspectives in Near-Infrared Fluorescent Organic Probes for Surgical Oncology

1,2‐Dioxetane‐based Chemiluminescence Probes for Tumor Optical Molecular Imaging